Epidemiological composition, clinical and treatment characteristics of the patient cohort of the German competence network for HIV/AIDS

European Journal of Medical Research

Volumn 14, Issue 10, 2009, Pages 415-425

  Jansen, Klaus ^a   Brockmeyer, N H ^a   Hahn, M ^b   Kaul, I ^b   Fenske, S ^c   Rausch, M ^d   Kuhlmann, B ^e   Ulmer, A ^f   Lauenroth Mai, E ^g   Harrer, T ^h   Hower, M ⁱ   Skaletz Rorowski, A ^a   Michalik, C ^j  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b IMSIE   (Germany)

^c Infektionsmedizinisches Centrum Hamburg   (Germany)

^d Gemeinschaftspraxis Fuggerstraße   (Germany)

^e Praxis Georgstrasse   (Germany)

^f Group Practice Ulmer Frietsch Müller Roll   (Germany)

^g Urologische Gemeinschaftspraxis Urologie Turmstraße   (Germany)

^h UNIVERSITY HOSPITAL ERLANGEN   (Germany)

ⁱ Institut für Arbeitsmedizin   (Germany)

^j UNIVERSITY OF COLOGNE   (Germany)

more..

Author keywords

Clinical research; Cohort study; Competence network HIV AIDS; Epidemiology; Germany; HIV AIDS; Profile

Indexed keywords

INTEGRASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE COURSE; DISEASE TRANSMISSION; FEMALE; GEOGRAPHIC DISTRIBUTION; GERMANY; HEALTH CARE PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; PREVALENCE; VIROTHERAPY; VIRUS LOAD;

EID: 70350102107     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: 10.1186/2047-783x-14-10-415     Document Type: Article

References (22)

1. Jansen K, Michalik C, Hahn, et al., and the Competence Network for HIV/AIDS. The Patient Cohort of the German Competence Network for HIV/AIDS (KompNet): A Profile. Eur J Med Res. 2009 August 12; 14(8): 323-331.
2. Robert Koch-Institut. HIV/AIDS in Deutschland - Eckdaten. 2009.
3. Robert Koch-Institut. HIV-Infektionen/AIDS: Jahresbericht 2008. Epi Bull. 2009; 21.
4. Robert Koch-Institut. Changing epidemiology and consequences for prevention. Invited lecture at the SOEDAK 2009, St Gallen.
5. Jaggy C, von Overbeck J, Ledergerber B, Schwarz C, Egger M, Rickenbach M et al. Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population. Lancet 2003;362(9387):877-878
6. Lloyd-Smith E, Brodkin E, Wood E, Kerr T, Tyndall MW, Montaner JSG et al. Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia. AIDS 2006;20(3):445-450
7. Swiss Cohort Study. Probability of dying and dropping out in the SHCS, 1991-2008. www.shcs.ch/html/figures/shcs-fig8.htm. [Accessed: 23rd July 2009].
8. Lohse N, Hansen AB, Gerstoft J, Obel N. Improved survival in HIV-infected persons: consequences and perspectives. J Antimicrob Chemother 2007;60:461-463 (Pubitemid 47303950)
9. Phillips AN, Gazzard B, Gilson R, et al. Rate of AIDS diseases or death in HIV-infected antiretroviral therapynaïve individuals with high CD4 count. AIDS 2007 Aug 20;21(13):1717-1721 (Pubitemid 47237558)
10. Steffan E, Kerschl V, Sokolowski S: Immigration and HIV/AIDS prevention in Germany - an interdisciplinary challenge. Euro Surveill. 2005; 10(1): E050120 4.
11. Robert Koch-Institut. HIV-Infektionen/AIDS-Erkrankungen: Halbjahresbericht I/2007. Epi Bull. 2007; B/2007.
12. Jansen K, Brockmeyer NH, Dlugay V, et al., and the Competence Network for HIV/AIDS. Clinical outcomes of HIV-positive patients (PLWHA) having different income status: Results of an analysis on basis of the Komp-Net cohort. Eur J Med Res. 2009; Jun 24; 14 (Supl I): 9.
13. Jansen K, Brockmeyer NH, Haastert B, et al., and the Competence Network for HIV/AIDS. Do patients treated by outpatient clinics or by private practitioners face differing treatment characteristics and clinical outcomes in Germany? Eur J Med Res. 2009; Jun 24; 14 (Supl I): 104.
14. Robert Koch-Institut. Zur Situation bei wichtigen Infektionskrankheiten in Deutschland. Virushepatitis B, C und D im Jahr 2008. Epi Bull. 2009; 20.
15. Breijt N, Gilleece Y, Fisher M: Acute hepatitis C: changing epidemiology and association with HIV infection. J HIV Ther. 2007; 12(1): 3-6.
16. Schmidt AJ, Vogel M, Rockstroh JK, Radun D: Risk Factors for Hepatitis C in HIV positive MSM. A preliminary evaluation of a case control study. Poster for the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Sydney 2007.
17. Rantala M, van de Laar MJ: Surveillance and epidemiology of hepatitis B and C in Europe - A review. Euro Surveill. 2008; 13 (21).
18. Marcus U. Michalik C, Brockmeyer N, et al. Late and Early Presenters in the German KompNet Cohort - a comparison of sociodemographic variables. Eur J Med Res.2009, Jun 24; 14 (Supl I): 17.
19. Marcus U, Schmidt AJ. What do men who have sex with men in Germany know about the most common sexually transmitted infections? Eur J Med Res.2009, Jun 24; 14 (Supl I): 16.
20. Antiretroviral therapy of HIV infection. German-Austrian guidelines (position in September 2008). Dtsch Med Wochenschr; 2009 Jan;134 Suppl 1:4-15.
21. Clumeck N, Pozniak A, Raffi F. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults. HIV Medicine 2008;9(2):65-71. (Pubitemid 351228129)
22. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. November 3, 2008; 1-139.